Search

everythinglearnresearchcommunity

for

Search:↓

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

The document concludes that PK/PD modeling is important for determining the safe and effective dosages of drugs.

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

EGFR inhibitors can cause yellowish skin eruptions.

A woman's liver problems improved after she stopped taking spironolactone.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

Lipid-coated silica nanoparticles penetrate human skin more deeply than bare silica nanoparticles.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Minoxidil tretinoin liposomal based hydrogel shows promise for effective treatment of hair loss by delivering both drugs at the same time.

Vitamin A might be a safe extra treatment for dogs with sebaceous adenitis, but more research is needed to prove its effectiveness.

Cardiovascular drugs can cause various skin problems, so recognizing these reactions is important.

Umbilical cord cells safely improve healing in long-term nonhealing wounds better than a placebo.

Ranitidine and finasteride lower TMAO levels, reducing heart and kidney damage by changing gut bacteria.

Treat limited stage small cell lung cancer with chemotherapy and radiation, and consider preventive brain radiation for better survival chances.

Rivaroxaban can cause liver injury, allergic reactions, blood vessel inflammation, and hair loss, but these side effects are rare.

Nanocarriers could improve how drugs are delivered through the skin but require more research to overcome challenges and ensure safety.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Some skin diseases and their treatments can negatively affect male fertility.

Cyclosporine A was found to increase hair growth in mouse whisker follicles.

The flutamide-loaded hydrogel is a promising, skin-friendly treatment for acne and hair loss, potentially requiring less frequent application.

An emollient PLUS balm with ADE-G1 significantly improved skin dryness and quality of life in cancer patients with xerosis.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Isotretinoin at a low dose for three months does not significantly affect hair growth.

Microemulsions could improve how drugs are delivered and absorbed in the body.

The document concludes that doctors should carefully consider off-label drug use in dermatology and always inform patients, while more research is needed on the safety and effectiveness of such practices.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Gene therapy shows promise for improving wound healing, but more research is needed for human use.